机译:用口服砷的三氧化锆的再生和维护方案治疗复发急性暴露细胞白血病的长期结果:一个15年的前瞻性研究
Department of MedicineQueen Mary HospitalHong Kong China;
Department of MedicineQueen Mary HospitalHong Kong China;
Department of MedicinePrincess Margaret HospitalHong Kong China;
Department of MedicinePrincess Margaret HospitalHong Kong China;
Department of MedicineUnited Christian HospitalHong Kong China;
Department of MedicinePamela Youde Eastern HospitalHong Kong China;
Department of MedicineTuen Mun HospitalHong Kong China;
Department of MedicineQueen Elizabeth HospitalHong Kong China;
Department of Clinical OncologyPrince of Wales HospitalHong Kong China;
Department of PathologyQueen Mary HospitalHong Kong China;
Department of MedicineQueen Mary HospitalHong Kong China;
Department of MedicineQueen Mary HospitalHong Kong China;
Department of MedicineQueen Mary HospitalHong Kong China;
Blood‐Med ClinicHong Kong China.;
Department of MedicineQueen Mary HospitalHong Kong China;
Department of MedicineQueen Mary HospitalHong Kong China;
acute promyelocytic leukemia; oral arsenic trioxide maintenance; relapse; second complete remission;
机译:用口服砷的三氧化锆的再生和维护方案治疗复发急性暴露细胞白血病的长期结果:一个15年的前瞻性研究
机译:比较三氧化二砷诱发并合并自体干细胞移植或三氧化二砷治疗的急性急性早幼粒细胞白血病患者的临床结局。
机译:急性早产细胞白血病复发管理,用预期砷三氧化砷中的方案治疗
机译:砷救生优于化疗和骨髓移植复发急性突出细胞细胞白血病:来自香港的十年经验
机译:在急性早幼粒细胞白血病中,新型砷化降火药(ZIO-101,S-二甲基ar-谷胱甘肽)比三氧化二砷更有效地诱导氧化应激和细胞凋亡。
机译:II期研究评估硼替佐米在三氧化二砷预先治疗的复发性急性早幼粒细胞白血病管理中的作用
机译:用口腔三氧化二砷的再生和维护方案治疗复发急性早产细胞白血病的长期结果:一个15年的前瞻性研究